Remimazolam is a benzodiazepine-type sedative that was developed using molecular-level techniques. A recent study showed the drug to have a faster onset, more predictable effects and shorter recovery time for patients than other drugs used during colonoscopy.
A study on the drug was published in the most recent issue of Anesthesia & Analgesia.
More Articles on Gastroenterology:
Eliminating Dietary Gluten May Decrease Chance of Developing Type 1 Diabetes
5 Key Trends in GI/Endoscopy
The Latest in GI Cancer: Q&A With Dr. Neville Bamji of New York Gastroenterology Associates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.